Tempest Therapeutics Revenue Growth & History (TPST)

Tempest Therapeutics reported $295,000 in revenue for fiscal 2017, a decrease of 54.82% from the previous fiscal year.

View full Tempest Therapeutics company overview

Tempest Therapeutics annual revenue and growth

Tempest Therapeutics annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20172017-12-31$295,000−$358,000−54.82%
20162016-12-31$653,000$376,000+135.74%
20152015-12-31$277,000$277,000
20142014-12-31$0$0
20132013-12-31$0
About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Primary source

SEC company filings

TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.

Review Tempest Therapeutics filings at SEC.gov ↗